Real environments, not the bench
Products are tested in the conditions they will actually be used — theatres, wards, control rooms, the field — not only on the bench where everything works.
Metriqx works with investors, health system buyers, and founders who need their evidence to hold up — not just look credible on a slide. We apply rigorous data science and human factors methodology to assess whether a technology does what it claims, for the people it claims to serve, in the conditions it will actually be used.
Most health technology validation is designed to pass, not to withstand scrutiny. That gap matters when it hits procurement review, due diligence, or post-deployment failure.
We produce independent, structured assessments of clinical and technical evidence. Our methodology draws on academic data science and human factors engineering — applied to the commercial realities of health technology development, investment, and procurement.
Outputs are built to survive independent review. That is the point.
Products are tested in the conditions they will actually be used — theatres, wards, control rooms, the field — not only on the bench where everything works.
Evidence built to withstand procurement review, investor due diligence, and regulatory questions — before they are asked, not after.
Surgeon, data scientist, and human factors researcher in one — the combination most validation needs and rarely has in a single pair of hands.
Full service lines launch soon. Right now, the quickest way in is a free discovery call and a focused half-day or full-day sprint.
A short, fixed-fee diagnostic for products making human-state claims. Three weeks. One clear answer.
Coming soonEnd-to-end study design and execution for products that need defensible evidence. Submission-ready outputs.
Coming soonFor products that work on the bench but struggle in real operational use. Specialist fieldwork by a clinician-researcher.
Coming soonCalibrated is a technical publication for health technology buyers and investors. Evidence briefs, methodology commentary, and sector analysis — without the vendor noise.
Substack — Coming soon
If you are evaluating a health technology investment, navigating procurement, or building something that needs to survive independent scrutiny — get in touch.